Titles and Roles
- Assistant Professor, Department of Pediatrics
- Emory University School of Medicine
- Pediatric Oncologist
- Pediatric Cancer
- Research Program
- Cancer Cell Biology
Dr. Goldsmith is board certified in Pediatric Hematology and Oncology by the American Board of Pediatrics. She is a member of several professional scientific societies including American Society of Pediatric Hematology and Oncology, the American Association for Cancer Research, the American Society of Clinical Oncology, and the Children’s Oncology Group.
Dr. Goldsmith received her Medical Degree from the University of Alabama School of Medicine in Birmingham, AL. She completed a residency in pediatrics and a fellowship in pediatric hematology and oncology at The Children's Hospital of Philadelphia in Philadelphia, PA.
Dr. Goldsmith's laboratory investigates the molecular mechanisms of chemotherapy resistance in pediatric neuroblastoma, focusing on experimental therapeutics that restore therapy sensitivity. Her research expertise is in apoptosis deregulation in cancer, the Bcl-2 family, and neurodevelopmental genes that play a role in therapy resistance. Her translational research provided the concept behind a first in pediatrics Phase I trial of simvastatin in combination with chemotherapy for recurrent solid/CNS tumors of childhood. She is co-chair of a NANT Precision Medicine Study for recurrent neuroblastoma and chair of the AflacST1402 trial. Dr. Goldsmith rounds out her bench to bedside personality as the clinical director of our Refractory and Recurrent Neuroblastoma Program where she and her team work to match a relapsed patient with the appropriate therapy for their recurrent disease.
Below is a listing of current federal grants for the above principal investigator.
Publications Publication Date
Dr. Goldsmith's has received several awards and honors including:
- American Cancer Society Mentored Research Scholars Awardee, 2008
- ASCO Young Investigator Award, 2005
- Caitlin Robb Foundation Award, 2004
- Italian Neuroblastoma Foundation Award—Advances in Neuroblastoma Research Meeting, Genoa, Italy, 2004